{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:58:05Z","timestamp":1791824285854,"version":"4.3.4"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The severity, progression, and outcomes of motor and non-motor symptoms in Parkinson\u2019s disease (PD) are quite variable. Following PD cohorts holds promise for identifying predictors of disease severity and progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PD patients (<jats:italic>N<\/jats:italic>\u2009=\u2009871) were enrolled at five sites. Enrollment occurred within 5 years of initial motor symptom onset. Disease progression was assessed annually for 2-to-10\u2009years after onset. Group-based trajectory modeling was used to identify groups differing in disease progression. Models were developed for UPDRS-III scores, UPDRS-III tremor and bradykinesia-rigidity subscores, Hoehn &amp;amp; Yahr (H&amp;amp;Y) stage, Mini-Mental Status Exam (MMSE) scores, and UPDRS-III, H&amp;amp;Y and MMSE scores considered together. Predictors of trajectory-group membership were modeled simultaneously with the trajectories. Kaplan\u2013Meier survival analysis evaluated survival free of PD outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The best fitting models identified three groups. One showed a relatively benign, slowly progressing trajectory (Group 1), a second showed a moderate, intermediately progressing trajectory (Group 2), and a third showed a more severe, rapidly progressing trajectory (Group 3). Stable trajectory-group membership occurred relatively early in the disease course, 5 years after initial motor symptom. Predictors of intermediate and more severe trajectory-group membership varied across the single variable models and the multivariable model jointly considering UPDRS-III, H&amp;amp;Y and MMSE scores. In the multivariable model, membership in Group 2 (28.4% of patients), relative to Group 1 (50.5%), was associated with male sex, younger age-at-onset, fewer education-years, pesticide exposure, absence of reported head injury, and akinetic\/rigid subtype at initial presentation. Membership in Group 3 (21.3%), relative to Group 1, was associated with older age-at-onset, fewer education-years, pesticide exposure, and the absence of a tremor-predominant subtype at initial presentation. Persistent freezing, persistent falls, and cognitive impairment occurred earliest and more frequently in Group 3, later and less frequently in Group 2, and latest and least frequently in Group 1. Furthermore, autonomic complications, dysphagia, and psychosis occurred more frequently in Groups 2 and 3 than in Group 1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Modeling disease course using multiple objective assessments over an extended follow-up duration identified groups that more accurately reflect differences in PD course, prognosis, and outcomes than assessing single parameters over shorter intervals.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2023.1240971","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T11:48:58Z","timestamp":1695815338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Multifactorial assessment of Parkinson\u2019s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort \u2013 extension of the LONG-PD study"],"prefix":"10.3389","volume":"15","author":[{"given":"Bruce A.","family":"Chase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejko","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Aasly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashvini P.","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Schoneburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninith","family":"Kartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navamon","family":"Aunaetitrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrius","family":"Maraganore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Markopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s10072-018-3522-z","article-title":"Disease progression in Parkinson subtypes: the PPMI dataset","volume":"39","author":"Aleksovski","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JPD-212860","article-title":"Longitudinal change and progression indicators using the movement disorder society-unified Parkinson's disease rating scale in two independent cohorts with early Parkinson's disease","volume":"12","author":"Bartl","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes \u2013 key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00702-023-02633-6","article-title":"The brain-first vs. body-first model of Parkinson's disease with comparison to alternative models","volume":"130","author":"Borghammer","year":"2023","journal-title":"J. Neural Transm. (Vienna)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/1531-8257(200009)15:5<819::aid-mds1009>3.0.co;2-p","article-title":"Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease","volume":"15","author":"Bower","year":"2000","journal-title":"Mov. Disord."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.26071","article-title":"GBA-associated Parkinson\u2019s disease: reduced survival and more rapid progression in a prospective longitudinal study","volume":"30","author":"Brockmann","year":"2014","journal-title":"Mov. Disord."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.24777","article-title":"Survival and dementia in GBA-associated Parkinson\u2019s disease: the mutation matters","volume":"80","author":"Celia","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JPD-225111","article-title":"Proposal for a biologic staging system of Parkinson's disease","volume":"13","author":"Chahine","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","article-title":"Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease","volume":"76","author":"De Pablo-Fern\u00e1ndez","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3233\/JPD-161055","article-title":"A consensus set of outcomes for Parkinson's disease from the international consortium for health outcomes measurement","volume":"7","author":"De Roos","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/acn3.51738","article-title":"North American prodromal Synucleinopathy (NAPS) consortium. Baseline characteristics of the North American prodromal Synucleinopathy cohort","volume":"10","author":"Elliott","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"648417","DOI":"10.3389\/fneur.2021.648417","article-title":"Editorial: celebrating the diversity of genetic research to dissect the pathogenesis of Parkinson's disease","volume":"12","author":"Farrer","year":"2021","journal-title":"Front. Neurol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of Parkinsons disease and their longitudinal progression: a prospective cohort comparison with other phenotypes","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/gps.4284","article-title":"The effects of cognitive reserve and lifestyle on cognition and dementia in Parkinson's disease--a longitudinal cohort study","volume":"31","author":"Hindle","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.20944\/preprints202304.0108.v1","article-title":"Towards a biological definition of Parkinson\u2019s disease","author":"H\u00f6glinger","year":"2023"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/0049124106292364","article-title":"Advances in group-based trajectory modeling and an SAS procedure for estimating them","volume":"1","author":"Jones","year":"2007","journal-title":"Sociol. Methods Res."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0049124113503141","article-title":"A note on a Stata plugin for estimating group-based trajectory models","volume":"42","author":"Jones","year":"2013","journal-title":"Soc. Meth. Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/brain\/awad072","article-title":"Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study","volume":"148","author":"Joza","year":"2023","journal-title":"Brain"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1177\/0962280215598665","article-title":"Introducing the fit-criteria assessment plot \u2013 a visualization tool to assist class enumeration in group-based trajectory modelling","volume":"26","author":"Klijn","year":"2017","journal-title":"Stat. Methods Med. Res."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S1474-4422(17)30328-9","article-title":"Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation","volume":"16","author":"Latourelle","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/jnnp-2018-318337","article-title":"Developing and validating Parkinson's disease subtypes and their motor and cognitive progression","volume":"89","author":"Lawton","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp-2021-327376","article-title":"Genetics of validated Parkinson's disease subtypes in the Oxford discovery and tracking Parkinson's cohorts","volume":"93","author":"Lawton","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/mds.27854","article-title":"Examining the reserve hypothesis in Parkinson's disease: a longitudinal study","volume":"34","author":"Lee","year":"2019","journal-title":"Mov. Disord."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"101834","DOI":"10.1016\/j.arr.2022.101834","article-title":"Premotor, nonmotor and motor symptoms of Parkinson's disease: a new clinical state of the art","volume":"84","author":"Leite Silva","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41531-022-00360-5","article-title":"Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination","volume":"8","author":"Li","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41588-021-00847-6","article-title":"Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson\u2019s disease","volume":"53","author":"Liu","year":"2021","journal-title":"Nat. Genet."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40035-022-00286-1","article-title":"Prodromal Parkinson's disease: hype or hope for disease-modification trials?","volume":"11","author":"Mahlknecht","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/jnnp-2017-317348","article-title":"Features of GBA-associated Parkinson's disease at presentation in the UK tracking Parkinson's study","volume":"89","author":"Malek","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fneur.2020.00548","article-title":"Longitudinal monitoring of Parkinson's disease in different ethnic cohorts: the DodoNA and LONG-PD study","volume":"11","author":"Markopoulou","year":"2020","journal-title":"Front. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e200092","DOI":"10.1212\/NXG.0000000000200092","article-title":"Genome-wide analysis of motor progression in Parkinson disease","volume":"9","author":"Mart\u00ednez Carrasco","year":"2023","journal-title":"Neurol. Genet."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JPD-202472","article-title":"Parkinson's disease subtypes: critical appraisal and recommendations","volume":"11","author":"Mestre","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mds.27492","article-title":"Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De novo Parkinson cohort (DeNoPa)","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov. Disord."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.3233\/JPD-225511","article-title":"Body-first subtype of Parkinson\u2019s disease with probably REM-sleep behavior disorder is associated with non-motor dominant phenotype","volume":"12","author":"Pavelka","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.parkreldis.2015.04.029","article-title":"Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: an international consensus statement","volume":"21","author":"Puschmann","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jalz.2012.10.001","article-title":"Comparative accuracies of two common screening instruments for classification of Alzheimer\u2019s disease, mild cognitive impairment, and healthy aging","volume":"9","author":"Roalf","year":"2013","journal-title":"Alzheimers Dement."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref01","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s1353-8020(99)00051-6","article-title":"Parkinson\u2019s disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis","volume":"6","author":"Schiess","year":"2000","journal-title":"Parkinsonism Relat. Disord"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/jnnp-2017-316213","article-title":"Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort. Version 2","volume":"89","author":"Simuni","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.28932","article-title":"GBA and APOE impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study","volume":"37","author":"Szwedo","year":"2022","journal-title":"Mov. Disord."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1101\/2022.07.07.22277297","article-title":"Genome-wide determinants of mortality and motor progression in Parkinson\u2019s disease","author":"Tan","year":"2022","journal-title":"medR\u03c7iv"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","article-title":"Parkinson disease subtypes","volume":"71","author":"Thenganatt","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.mayocp.2019.01.043","article-title":"Comparison of the short test of mental status and the Montreal cognitive assessment across the cognitive spectrum","volume":"94","author":"Townley","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.brainresrev.2007.07.007","article-title":"Complex mental activity and the aging brain: molecular, cellular and cortical network mechanisms","volume":"56","author":"Valenzuela","year":"2007","journal-title":"Brain Res. Rev."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/mds.26062","article-title":"Conversion between mini-mental state examination, Montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease","volume":"29","author":"van Steenoven","year":"2014","journal-title":"Mov. Disord."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-023-00556-3","article-title":"Two distinct trajectories of clinical and neurodegeneration events in Parkinson\u2019s disease","volume":"9","author":"Zhou","year":"2023","journal-title":"NPJ Parkinson\u2019s Dis."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1240971\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T11:49:02Z","timestamp":1695815342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1240971\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":47,"alternative-id":["10.3389\/fnagi.2023.1240971"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2023.1240971","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"article-number":"1240971"}}